TREA

79213643 - PROSILIC

Follow

Information

  • Trademark
  • 79213643
  • Serial Number
    79213643
  • Registration Number
    5614010
  • Filing Date
    March 08, 2017
    7 years ago
  • Registration Date
    November 27, 2018
    6 years ago
  • Transaction Date
    October 14, 2024
    2 months ago
  • Status Date
    November 27, 2018
    6 years ago
  • Published for Opposition Date
    September 11, 2018
    6 years ago
  • Location Date
    April 25, 2019
    5 years ago
  • Status Code
    700
  • Current Location
    POST REGISTRATION
    Employee Name
    CARROLL, DORITT
  • Attorney Docket Number
    RD2024
    Attorney Name
    Craine, Dean A
    Law Office Assigned Location Code
    M70
  • Owners
Information
Mark Drawing Code
4
Mark Identification
PROSILIC
Case File Statements
  • B00001: In the statement, line 28, "winkles", should be deleted, and, "wrinkles", should be inserted.
  • GS0051: Chemicals and chemical preparations, namely, antiviral pharmaceutical preparations, anti-infective pharmaceutical preparations, anti-inflammatory pharmaceutical preparations, antiseptic pharmaceutical preparations, antibacterial pharmaceutical preparations, antibiotic pharmaceutical preparations; antifungal pharmaceutical preparations, anti-fibrotic pharmaceutical preparations; chemicals and chemical preparations, namely, pharmaceutical preparation for skin care; chemicals and chemical preparations, namely, pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, inflammatory diseases and disorders, respiratory and pulmonary diseases and disorders, immune system related diseases and disorders, hematological diseases and disorders, oncological diseases and disorders, urological diseases and disorders, gastro-intestinal diseases, eye diseases and conditions, heart rhythm disorders, kidney and nephropathic diseases, hematological disorders, diabetes, hypertension, skin disorders, damaged skin and tissue, [ winkles ] * wrinkles *, wounds and allergies, insect bites, dermatological diseases and disorders, HIV, cancer and tumors, bone diseases, arthritis, cardiopulmonary, infectious diseases, blood disorders, pain, sepsis, alopecia, obesity, cognitive disorders diseases, neurological disorders, hormonal disorders, disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; drug delivery agents consisting of nanoparticle compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; drug delivery agents consisting of silicon compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; drug delivery agents consisting of porous silicon compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals skin care preparations; drug delivery agents in the form of powders, liquids and gels that provide controlled release of the active ingredients for a wide variety of pharmaceutical, nutraceutical and veterinary products
  • GS0011: Chemical preparations for use in industry; chemical preparations for scientific purposes; biochemical substances and biochemical preparations for use in industry, science and research, namely, excipients for use in the manufacture of pharmaceutical preparations, cosmetic preparations, nutraceutical preparations, veterinary preparations, dietary supplements, foods and beverages and pharmaceutical preparations for topical use; reagents and substrates, namely, chemical compounds for use in patterning at nano scale or near nano scale; silicon for use in industry, science and research; pure non-metallic silicon sold in nanoparticle form for use in industry, science and research; pure non-metallic porous silicon sold in nanoparticle form for use in industry, science and research; silicon for use in stabilising of enzymes of chemical, biochemical and biological substances for use in industry and for scientific research purposes
Case File Event Statements
  • 8/7/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/3/2017 - 7 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 8/7/2017 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/8/2017 - 7 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/9/2017 - 7 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 8/10/2017 - 7 years ago
    6 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 8/10/2017 - 7 years ago
    7 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 8/11/2017 - 7 years ago
    8 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 8/25/2017 - 7 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/7/2018 - 6 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/14/2018 - 6 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 2/15/2018 - 6 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/15/2018 - 6 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/12/2018 - 6 years ago
    14 - FINAL REFUSAL WRITTEN Type: CNFR
  • 3/12/2018 - 6 years ago
    16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 3/12/2018 - 6 years ago
    15 - FINAL REFUSAL E-MAILED Type: GNFR
  • 7/28/2018 - 6 years ago
    17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 7/28/2018 - 6 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/28/2018 - 6 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/6/2018 - 6 years ago
    22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 8/6/2018 - 6 years ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 8/6/2018 - 6 years ago
    21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/14/2018 - 6 years ago
    32 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/6/2018 - 6 years ago
    23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 8/6/2018 - 6 years ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/22/2018 - 6 years ago
    25 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 8/22/2018 - 6 years ago
    26 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/22/2018 - 6 years ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 9/7/2018 - 6 years ago
    28 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 9/11/2018 - 6 years ago
    29 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/11/2018 - 6 years ago
    30 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/27/2018 - 6 years ago
    31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/25/2019 - 5 years ago
    39 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 2/28/2019 - 5 years ago
    33 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 3/7/2019 - 5 years ago
    34 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 3/7/2019 - 5 years ago
    35 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 3/29/2019 - 5 years ago
    36 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 4/4/2019 - 5 years ago
    37 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R
  • 4/24/2019 - 5 years ago
    38 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 11/27/2023 - a year ago
    42 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 1/6/2020 - 4 years ago
    40 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 1/30/2020 - 4 years ago
    41 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA
  • 10/14/2024 - 2 months ago
    43 - TEAS SECTION 71 RECEIVED Type: ES71